Inotiv, Inc.(NOTV)Earnings, Financials & Key Ratios
NOTV•NASDAQ
$0.31
$11M mkt cap·Price updated May 6, 2026
SectorHealthcareIndustryDiagnostics & ResearchSub-IndustryContract Research and Preclinical Services
AboutInotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment provides analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to identify and measure drug and metabolite concentrations in complex biological matrices; in vivo sampling services for the continuous monitoring of chemical changes in life; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; non-clinical toxicology and pathology services; and climate-controlled archiving services for its customers' data and samples. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; liquid chromatography and electrochemistry instruments platforms; analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; and in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It has an agreement with BioVaxys to conduct preclinical toxicity studies for its Covid-T Immunodiagnostic program. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.Show more
- Revenue$513M+4.5%
- EBITDA$25M+185.4%
- Net Income-$69M+36.7%
- EPS (Diluted)-2.11+49.6%
- Gross Margin12.68%-44.0%
- EBITDA Margin4.88%+181.7%
- Operating Margin-6.02%+65.8%
- Net Margin-13.38%+39.5%
- ROE-44.78%+9.4%
- ROIC-4.15%+60.2%
- Debt/Equity3.01+15.2%
- Interest Coverage-0.55+70.4%
NOTV Key Insights
Inotiv, Inc. (NOTV) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y sales CAGR of 53.4%
- ✓Trading at only 0.1x book value
✗Weaknesses
- ✗High debt to equity ratio of 3.0x
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 9 (bottom 9%)
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Shares diluted 25.3% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
NOTV Price & Volume
Inotiv, Inc. (NOTV) stock price & volume — 10-year historical chart
Loading chart...
NOTV Growth Metrics
Inotiv, Inc. (NOTV) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years36.59%
5 Years53.36%
3 Years-2.15%
TTM4.54%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM36.72%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM47.02%
Return on Capital
10 Years-6.11%
5 Years-6.87%
3 Years-10.07%
Last Year-7.05%
NOTV Peer Comparison
Inotiv, Inc. (NOTV) competitors in Contract Research and Preclinical Services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 CRL | 8.97B | 181.73 | -62.45 | -0.85% | -3.59% | -4.34% | 0.95 | |
 HALO | 7.81B | 66.35 | 25.92 | 37.55% | 22.69% | 6.49% | ||
 PCRX | 931.85M | 23.69 | 148.06 | 3.63% | 1.27% | 1.31% | 0.66 | |
 ICLR | 9.48B | 124.13 | 13.03 | 1.99% | 7.4% | 6.32% | 0.38 | |
 MEDP | 12.19B | 426.79 | 27.93 | 19.97% | 17.19% | 120.89% | 0.55 | |
 PRA | 1.27B | 24.60 | 24.85 | -2.67% | 6.04% | 4.95% | 0.32 | |
 NVCR | 1.88B | 16.50 | -13.52 | 8.28% | -25.66% | -50.82% | 0.85 | |
 TMO | 175.76B | 472.95 | 26.66 | 3.91% | 15.18% | 13.23% | 0.76 |
Compare NOTV vs Peers
Inotiv, Inc. (NOTV) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
NOTV Income Statement
Inotiv, Inc. (NOTV) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | Sep'25 |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 24.24M | 26.35M | 43.62M | 60.47M | 89.61M | 547.66M | 572.42M | 490.74M | 513.02M |
| Revenue Growth % | 18.59% | 8.68% | 65.55% | 38.64% | 48.18% | 511.19% | 4.52% | -14.27% | 4.54% |
| Cost of Goods Sold | 16.55M | 18.23M | 30.7M | 42.23M | 59.45M | 390.44M | 406.98M | 379.57M | 447.97M |
| COGS % of Revenue | 68.25% | 69.19% | 70.38% | 69.84% | 66.35% | 71.29% | 71.1% | 77.35% | 87.32% |
| Gross Profit | 7.7M▲ 0% | 8.12M▲ 5.4% | 12.92M▲ 59.2% | 18.24M▲ 41.1% | 30.16M▲ 65.4% | 157.21M▲ 421.3% | 165.44M▲ 5.2% | 111.17M▼ 32.8% | 65.05M▼ 41.5% |
| Gross Margin % | 31.75% | 30.81% | 29.62% | 30.16% | 33.65% | 28.71% | 28.9% | 22.65% | 12.68% |
| Gross Profit Growth % | 73.94% | 5.44% | 59.2% | 41.14% | 65.36% | 421.33% | 5.24% | -32.8% | -41.48% |
| Operating Expenses | 6.42M | 8.1M | 13.07M | 21.3M | 35.77M | 184.66M | 246.9M | 197.58M | 95.95M |
| OpEx % of Revenue | 26.48% | 30.75% | 29.98% | 35.22% | 39.92% | 33.72% | 43.13% | 40.26% | 18.7% |
| Selling, General & Admin | 5.95M | 7.51M | 12.45M | 20.35M | 33.89M | 99.09M | 127.32M | 97.92M | 92.24M |
| SG&A % of Revenue | 24.56% | 28.49% | 28.54% | 33.65% | 37.82% | 18.09% | 22.24% | 19.95% | 17.98% |
| Research & Development | 465K | 596K | 627K | 950K | 405K | 0 | 0 | 0 | 0 |
| R&D % of Revenue | 1.92% | 2.26% | 1.44% | 1.57% | 0.45% | - | - | - | - |
| Other Operating Expenses | 5K | 6K | 9K | 15K | 1.48M | 85.57M | 119.58M | 99.66M | 3.71M |
| Operating Income | 1.28M▲ 0% | 14K▼ 98.9% | -153K▼ 1192.9% | -3.06M▼ 1902.0% | 1.53M▲ 150.1% | -27.45M▼ 1889.2% | -81.46M▼ 196.8% | -86.41M▼ 6.1% | -30.9M▲ 64.2% |
| Operating Margin % | 5.27% | 0.05% | -0.35% | -5.07% | 1.71% | -5.01% | -14.23% | -17.61% | -6.02% |
| Operating Income Growth % | 142.04% | -98.9% | -1192.86% | -1901.96% | 150.08% | -1889.24% | -196.79% | -6.07% | 64.24% |
| EBITDA | 2.96M | 1.87M | 2.56M | 1.92M | 9.1M | 21.88M | -26.74M | -29.29M | 25.03M |
| EBITDA Margin % | 12.2% | 7.1% | 5.88% | 3.17% | 10.15% | 3.99% | -4.67% | -5.97% | 4.88% |
| EBITDA Growth % | 299.33% | -36.78% | 37.11% | -25.23% | 374.54% | 140.49% | -222.24% | -9.52% | 185.45% |
| D&A (Non-Cash Add-back) | 1.68M | 1.86M | 2.72M | 4.98M | 7.56M | 49.32M | 54.72M | 57.12M | 55.93M |
| EBIT | 1.28M | 20K | -144K | -3.05M | 7.8M | -322.75M | -81.22M | -83.88M | -31.18M |
| Net Interest Income | -375K | -274K | -642K | -1.49M | -1.68M | -29.7M | -43.02M | -46.88M | -56.59M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 375K | 274K | 642K | 1.49M | 1.68M | 29.7M | 43.02M | 46.88M | 56.59M |
| Other Income/Expense | -370K | -268K | -633K | -1.48M | 501K | -89M | -42.78M | -44.35M | -56.87M |
| Pretax Income | 908K▲ 0% | -254K▼ 128.0% | -786K▼ 209.4% | -4.54M▼ 477.4% | 6.12M▲ 234.8% | -352.45M▼ 5859.9% | -124.24M▲ 64.7% | -130.76M▼ 5.2% | -87.77M▲ 32.9% |
| Pretax Margin % | 3.75% | -0.96% | -1.8% | -7.5% | 6.83% | -64.36% | -21.7% | -26.65% | -17.11% |
| Income Tax | 24K | -60K | 4K | 147K | -4.78M | -15.19M | -19.34M | -21.88M | -19.14M |
| Effective Tax Rate % | 2.64% | 23.62% | -0.51% | -3.24% | -78.05% | 4.31% | 15.57% | 16.73% | 21.81% |
| Net Income | 884K▲ 0% | -194K▼ 121.9% | -790K▼ 307.2% | -4.68M▼ 493.0% | 10.89M▲ 332.6% | -337.26M▼ 3195.6% | -105.14M▲ 68.8% | -108.44M▼ 3.1% | -68.63M▲ 36.7% |
| Net Margin % | 3.65% | -0.74% | -1.81% | -7.75% | 12.16% | -61.58% | -18.37% | -22.1% | -13.38% |
| Net Income Growth % | 127.37% | -121.95% | -307.22% | -493.04% | 332.55% | -3195.57% | 68.83% | -3.14% | 36.72% |
| Net Income (Continuing) | 884K | -194K | -790K | -4.68M | 10.89M | -337.26M | -104.9M | -108.89M | -68.63M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | -606K | -664K | 0 | 0 |
| EPS (Diluted) | 0.10▲ 0% | -0.02▼ 122.1% | -0.08▼ 244.3% | -0.43▼ 465.0% | 0.79▲ 283.7% | -13.85▼ 1853.2% | -4.10▲ 70.4% | -4.19▼ 2.2% | -2.11▲ 49.6% |
| EPS Growth % | 125% | -122.1% | -244.34% | -465.05% | 283.72% | -1853.16% | 70.4% | -2.2% | 49.64% |
| EPS (Basic) | 0.11 | -0.02 | -0.08 | -0.43 | 0.83 | -13.85 | -4.10 | -4.19 | -2.11 |
| Diluted Shares Outstanding | 8.73M | 8.77M | 10.38M | 10.85M | 13.87M | 24.35M | 25.64M | 25.9M | 32.45M |
| Basic Shares Outstanding | 8.18M | 8.77M | 10.38M | 10.85M | 13.19M | 24.35M | 25.64M | 25.9M | 32.45M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
NOTV Balance Sheet
Inotiv, Inc. (NOTV) balance sheet — assets, liabilities & shareholders' equity
| Line item | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | Sep'25 |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 5.31M | 8.06M | 12.42M | 15.3M | 189.02M | 232.98M | 213.8M | 163.41M | 194.59M |
| Cash & Short-Term Investments | 434K | 773K | 606K | 1.41M | 138.92M | 18.52M | 35.49M | 21.43M | 21.74M |
| Cash Only | 434K | 773K | 606K | 1.41M | 138.92M | 18.52M | 35.49M | 21.43M | 21.74M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 3.15M | 5.14M | 9.52M | 10.82M | 28.36M | 100.07M | 90.42M | 77.44M | 78.22M |
| Days Sales Outstanding | 47.35 | 71.21 | 79.67 | 65.33 | 115.54 | 66.7 | 57.66 | 57.6 | 55.65 |
| Inventory | 913K | 1.18M | 1.09M | 700K | 602K | 71.44M | 56.1M | 18.17M | 45.74M |
| Days Inventory Outstanding | 20.14 | 23.67 | 13.02 | 6.05 | 3.7 | 66.79 | 50.31 | 17.48 | 37.27 |
| Other Current Assets | 0 | 0 | 0 | 0 | 21.13M | 42.95M | 8.24M | 4.86M | 48.89M |
| Total Non-Current Assets | 15.11M | 23.21M | 29.56M | 46.29M | 132.84M | 729.92M | 642.73M | 617.95M | 576.52M |
| Property, Plant & Equipment | 14.96M | 16.61M | 22.83M | 37.51M | 56.4M | 218.69M | 229.93M | 237.49M | 227.08M |
| Fixed Asset Turnover | 1.62x | 1.59x | 1.91x | 1.61x | 1.59x | 2.50x | 2.49x | 2.07x | 2.26x |
| Goodwill | 38K | 3.07M | 3.62M | 4.37M | 51.93M | 157.82M | 94.29M | 94.29M | 94.29M |
| Intangible Assets | 0 | 3.32M | 2.87M | 4.26M | 24.23M | 345.89M | 308.43M | 274.4M | 240.2M |
| Long-Term Investments | 87K | 115K | 130K | 75K | 0 | 0 | 3.68M | 6.08M | 7.64M |
| Other Non-Current Assets | 108K | 30K | 79K | 156K | 281K | 7.52M | 6.4M | 5.69M | 7.32M |
| Total Assets | 20.42M▲ 0% | 31.27M▲ 53.1% | 41.98M▲ 34.3% | 61.59M▲ 46.7% | 321.86M▲ 422.6% | 962.9M▲ 199.2% | 856.53M▼ 11.0% | 781.36M▼ 8.8% | 771.11M▼ 1.3% |
| Asset Turnover | 1.19x | 0.84x | 1.04x | 0.98x | 0.28x | 0.57x | 0.67x | 0.63x | 0.67x |
| Asset Growth % | -3.42% | 53.15% | 34.26% | 46.72% | 422.55% | 199.17% | -11.05% | -8.78% | -1.31% |
| Total Current Liabilities | 7.72M | 11.8M | 17.48M | 31.64M | 55.11M | 164.1M | 132.19M | 119.04M | 556.78M |
| Accounts Payable | 2.05M | 3.19M | 4.94M | 3.2M | 6.16M | 28.7M | 32.56M | 33.53M | 48.53M |
| Days Payables Outstanding | 45.27 | 63.91 | 58.75 | 27.62 | 37.84 | 26.82 | 29.2 | 32.24 | 39.54 |
| Short-Term Debt | 352K | 996K | 2.19M | 6.86M | 11.4M | 22.98M | 7.95M | 3.54M | 405.12M |
| Deferred Revenue (Current) | 2.98M | 4.92M | 6.73M | 11.39M | 26.61M | 68.64M | 18.93M | 41.99M | 51.51M |
| Other Current Liabilities | 989K | 1.03M | 968K | 3.49M | 3.5M | 68.64M | 49.5M | 5M | 44.23M |
| Current Ratio | 0.69x | 0.68x | 0.71x | 0.48x | 3.43x | 1.42x | 1.62x | 1.37x | 0.35x |
| Quick Ratio | 0.57x | 0.58x | 0.65x | 0.46x | 3.42x | 0.98x | 1.19x | 1.22x | 0.27x |
| Cash Conversion Cycle | 22.23 | 30.97 | 33.93 | 43.76 | 81.4 | 106.66 | 78.77 | 42.84 | 53.38 |
| Total Non-Current Liabilities | 4.23M | 8.58M | 13.79M | 22.36M | 161.62M | 439.04M | 455.85M | 491.81M | 78.3M |
| Long-Term Debt | 4.16M | 8.55M | 13.77M | 18.83M | 154.21M | 330.68M | 369.8M | 389.8M | 44.34M |
| Capital Lease Obligations | 69K | 37K | 18K | 3.39M | 6.59M | 24.89M | 29.61M | 40.01M | 46.77M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 141K | 344K | 77.03M | 50.06M | 27.04M | 5.57M |
| Other Non-Current Liabilities | 0 | 0 | 0 | 3.39M | 473K | 6.44M | 6.37M | 34.96M | -18.39M |
| Total Liabilities | 11.95M | 20.38M | 31.27M | 54M | 216.73M | 603.13M | 588.04M | 610.86M | 635.09M |
| Total Debt | 4.71M | 9.67M | 16.63M | 36.41M | 174.19M | 386.49M | 417.64M | 445.12M | 409.02M |
| Net Debt | 4.27M | 8.89M | 16.03M | 35.01M | 35.27M | 367.98M | 382.15M | 423.69M | 387.28M |
| Debt / Equity | 0.56x | 0.89x | 1.55x | 4.79x | 1.66x | 1.07x | 1.56x | 2.61x | 3.01x |
| Debt / EBITDA | 1.59x | 5.17x | 6.49x | 18.99x | 19.15x | 17.67x | - | - | 16.34x |
| Net Debt / EBITDA | 1.44x | 4.76x | 6.25x | 18.26x | 3.88x | 16.82x | - | - | 15.48x |
| Interest Coverage | 3.41x | 0.05x | -0.24x | -2.06x | 0.91x | -0.92x | -1.89x | -1.84x | -0.55x |
| Total Equity | 8.47M▲ 0% | 10.88M▲ 28.5% | 10.71M▼ 1.6% | 7.6M▼ 29.1% | 105.13M▲ 1284.0% | 359.77M▲ 242.2% | 268.49M▼ 25.4% | 170.5M▼ 36.5% | 136.03M▼ 20.2% |
| Equity Growth % | 13.53% | 28.55% | -1.6% | -29.08% | 1283.99% | 242.22% | -25.37% | -36.5% | -20.22% |
| Book Value per Share | 0.97 | 1.24 | 1.03 | 0.70 | 7.58 | 14.77 | 10.47 | 6.58 | 4.19 |
| Total Shareholders' Equity | 8.47M | 10.88M | 10.71M | 7.6M | 105.13M | 360.37M | 269.15M | 170.5M | 136.03M |
| Common Stock | 2.02M | 2.52M | 2.59M | 2.71M | 3.94M | 6.36M | 6.41M | 6.47M | 8.55M |
| Retained Earnings | -16.04M | -16.23M | -17.1M | -21.91M | -11.02M | -348.28M | -453.28M | -562.16M | -630.81M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -27.88M | -31.82M | 0 | 0 | 0 | -5.5M | 330K | 1.41M | 2.23M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | -606K | -664K | 0 | 0 |
NOTV Cash Flow Statement
Inotiv, Inc. (NOTV) cash flow — operating, investing & free cash flow history
| Line item | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | Sep'25 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 1.24M | 3.49M | 1.78M | 1.29M | 10.75M | -5.22M | 27.88M | -6.8M | -10.46M |
| Operating CF Margin % | 5.1% | 13.24% | 4.07% | 2.13% | 11.99% | -0.95% | 4.87% | -1.39% | -2.04% |
| Operating CF Growth % | 16.6% | 182.12% | -49.04% | -27.41% | 733.02% | -148.55% | 634.46% | -124.41% | -53.64% |
| Net Income | 884K | -194K | -790K | -4.68M | 10.89M | -337.26M | -104.9M | -108.89M | -68.63M |
| Depreciation & Amortization | 1.68M | 1.88M | 2.72M | 3.93M | 6.27M | 49.32M | 54.72M | 57.12M | 55.93M |
| Stock-Based Compensation | 19K | 134K | 278K | 540K | 1.79M | 24.2M | 7.84M | 6.74M | 6.03M |
| Deferred Taxes | 0 | 0 | 0 | 202K | -4.99M | -17.84M | -25.81M | -23.25M | -21.61M |
| Other Non-Cash Items | -5K | -4K | -336K | 356K | -12.86M | 316.63M | 79.08M | 8.87M | 18.97M |
| Working Capital Changes | -1.34M | 1.68M | -92K | 948K | 9.64M | -40.28M | 16.96M | 52.6M | -1.14M |
| Change in Receivables | -941K | -589K | -3.09M | -620K | -11.95M | -23.84M | 9.55M | 14.17M | -3.83M |
| Change in Inventory | 540K | -269K | 87K | 395K | 98K | -35.2M | 14.01M | 38.21M | -27.59M |
| Change in Payables | -913K | 980K | 1.02M | -2.05M | 2.62M | -8.04M | 5.96M | 613K | 12.34M |
| Cash from Investing | -339K | -8.07M | -8.15M | -10.13M | -54.06M | -333.72M | -28.75M | -16.83M | -12.89M |
| Capital Expenditures | -347K | -1.32M | -6.88M | -6.2M | -12.47M | -36.3M | -27.5M | -22.31M | -16.61M |
| CapEx % of Revenue | 1.43% | 5% | 15.77% | 10.25% | 13.92% | 6.63% | 4.8% | 4.55% | 3.24% |
| Acquisitions | 8K | -6.76M | -1.27M | -3.93M | -41.59M | -297.71M | 1.11M | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | 8K | 2K | 0 | -3.93M | 2K | 290K | -2.37M | 5.48M | 3.72M |
| Cash from Financing | -849K | 4.93M | 6.21M | 9.64M | 198.83M | 203.15M | 15.87M | 9.68M | 23.7M |
| Debt Issued (Net) | -920K | 5.04M | 6.29M | 9.74M | 155.84M | 214.26M | 15.84M | 13.55M | -1.95M |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 1000K | 0 | 0 | 0 | 1000K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 71K | -112K | -88K | -101K | -5.98M | -11.11M | 33K | -3.87M | -1.88M |
| Net Change in Cash | 48K▲ 0% | 339K▲ 606.3% | -167K▼ 149.3% | 800K▲ 579.0% | 155.52M▲ 19339.8% | -137.94M▼ 188.7% | 16.51M▲ 112.0% | -14.06M▼ 185.2% | 309K▲ 102.2% |
| Free Cash Flow | 889K▲ 0% | 2.17M▲ 144.1% | -5.1M▼ 335.1% | -4.91M▲ 3.7% | -1.73M▲ 64.8% | -41.52M▼ 2305.4% | 380K▲ 100.9% | -29.11M▼ 7761.8% | -27.07M▲ 7.0% |
| FCF Margin % | 3.67% | 8.24% | -11.7% | -8.12% | -1.93% | -7.58% | 0.07% | -5.93% | -5.28% |
| FCF Growth % | 553.57% | 144.09% | -335.07% | 3.74% | 64.85% | -2305.39% | 100.92% | -7761.84% | 7.02% |
| FCF per Share | 0.10 | 0.25 | -0.49 | -0.45 | -0.12 | -1.70 | 0.01 | -1.12 | -0.83 |
| FCF Conversion (FCF/Net Income) | 1.40x | -17.97x | -2.25x | -0.28x | 0.99x | 0.02x | -0.27x | 0.06x | 0.15x |
| Interest Paid | 0 | 0 | 0 | 0 | 1.27M | 17.06M | 35.46M | 36.14M | 38.84M |
| Taxes Paid | 0 | 0 | 0 | 0 | 8K | 479K | 7.15M | 1.84M | 749K |
NOTV Key Ratios
Inotiv, Inc. (NOTV) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -35.54% | 11.1% | -2.01% | -7.32% | -51.19% | 19.33% | -145.09% | -33.47% | -49.41% | -44.78% |
| Return on Invested Capital (ROIC) | -16.42% | 7.62% | 0.06% | -0.49% | -6.63% | 1.26% | -4.74% | -8.86% | -10.41% | -4.15% |
| Gross Margin | 21.65% | 31.75% | 30.81% | 29.62% | 30.16% | 33.65% | 28.71% | 28.9% | 22.65% | 12.68% |
| Net Margin | -15.8% | 3.65% | -0.74% | -1.81% | -7.75% | 12.16% | -61.58% | -18.37% | -22.1% | -13.38% |
| Debt / Equity | 0.72x | 0.56x | 0.89x | 1.55x | 4.79x | 1.66x | 1.07x | 1.56x | 2.61x | 3.01x |
| Interest Coverage | -7.62x | 3.41x | 0.05x | -0.24x | -2.06x | 0.91x | -0.92x | -1.89x | -1.84x | -0.55x |
| FCF Conversion | -0.33x | 1.40x | -17.97x | -2.25x | -0.28x | 0.99x | 0.02x | -0.27x | 0.06x | 0.15x |
| Revenue Growth | -9.94% | 18.59% | 8.68% | 65.55% | 38.64% | 48.18% | 511.19% | 4.52% | -14.27% | 4.54% |
NOTV Frequently Asked Questions
Inotiv, Inc. (NOTV) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Inotiv, Inc. (NOTV) reported $513.0M in revenue for fiscal year 2025. This represents a 3343% increase from $14.9M in 1997.
Inotiv, Inc. (NOTV) grew revenue by 4.5% over the past year. Growth has been modest.
Inotiv, Inc. (NOTV) reported a net loss of $68.6M for fiscal year 2025.
Dividend & Returns
Inotiv, Inc. (NOTV) has a return on equity (ROE) of -44.8%. Negative ROE indicates the company is unprofitable.
Inotiv, Inc. (NOTV) had negative free cash flow of $27.1M in fiscal year 2025, likely due to heavy capital investments.
Explore More NOTV
Inotiv, Inc. (NOTV) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates